Leerink Partners Remains Bullish on Nxstage Medical (NXTM) After Visiting with Management
Tweet Send to a Friend
Leerink Partners reiterated an Outperform rating and $24.00 price target on NxStage Medical (NASDAQ: NXTM) following a visit to a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE